title: [Contribution of dual CD13/CD14 markers in combination with CD34 for the collection of peripheral hematopoietic stem cells].
abstract: We evaluated the reliability of a flow cytometry technique for counting mononuclear cells (MNCs) in cytapheresis products. Eighty freshly-prepared samples of peripheral stem cells were studied using a dual immunolabeling technique with antibodies to CD13/CD14, and were also labeled with anti-CD34. Results of this immunophenotype determination were compared to those of the conventional method for counting MNCs under the microscope. Dual CD13/CD14 labeling was found to be a simple and reliable method for counting MNCs in the presence of immature and stimulated cells. When used in combination with CD34 labeling, the dual immunolabeling method helped improve the evaluation of the quality of peripheral stem cell grafts.
authors.affiliation: Laboratoire d'Immunologie, Etablissement de Transfusion Sanguine de Lyon, France.
authors.forename: B
authors.initials: B
authors.lastname: Durand
authors.forename: J
authors.initials: J
authors.lastname: Bernaud
authors.forename: A
authors.initials: A
authors.lastname: Raffin
authors.forename: Y
authors.initials: Y
authors.lastname: Mérieux
authors.forename: D
authors.initials: D
authors.lastname: Rigal
authors.forename: G
authors.initials: G
authors.lastname: Salles
authors.forename: B
authors.initials: B
authors.lastname: Coiffier
mesh_terms: D018952:Antigens, CD34 / Q000276:immunology*; D015415:Biomarkers; D001772:Blood Cell Count; D018826:CD13 Antigens / Q000276:immunology*; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000276:immunology* / Q000473:pathology; D006689:Hodgkin Disease / Q000473:pathology; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000276:immunology*; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology; D009101:Multiple Myeloma / Q000473:pathology
chemical_list: D018952:Antigens, CD34; D015415:Biomarkers; D018950:Lipopolysaccharide Receptors; D018826:CD13 Antigens
vernacular_title: Apport du double marquage CD13/CD14 associé au marquage CD34 pour le prélèvement des cellules souches hematopoïétiques périphériques.